Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications

Volkow, Nora D., Wang, Gene‐Jack, Fowler, Joanna S., Logan, Jean, Franceschi, Dinko, Maynard, Laurence, Ding, Yu‐Shin, Gatley, Samuel J. +3 more·2002·Synapse
DOI 10.1002/syn.10038

Cited by (321)

Items 101–200 of 321

  1. Polymorphisms of the Dopamine Transporter Gene
    Tatiana Roman, Luís Augusto Rohde, Mara Helena Hutz · 2004 · American Journal of PharmacoGenomics
  2. Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD
    Johnson, Katherine A., Barry, Edwina, Bellgrove, Mark A., Cox, Marie, Kelly, Simon P., Dáibhis, Aoife, Daly, Michael, Keavey, Michelle, Watchorn, Amy, Fitzgerald, Michael et al. · 2008 · Neuropsychologia
  3. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention‐deficit/hyperactivity disorder
    Anne‐Claude Bedard, Mark A. Stein, Jeffrey M. Halperin, Beth Krone, Estrella Rajwan, Jeffrey H. Newcorn · 2014 · Journal of Child Psychology and Psychiatry
  4. The Norepinephrine Transporter in Attention-Deficit/Hyperactivity Disorder Investigated With Positron Emission Tomography
    Vanicek, Thomas, Spies, Marie, Rami-Mark, Christina, Savli, Markus, Höflich, Anna, Kranz, Georg S., Hahn, Andreas, Kutzelnigg, Alexandra, Traub-Weidinger, Tatjana, Mitterhauser, Markus et al. · 2014 · JAMA Psychiatry
  5. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders
    Kanwar Virdee, Paul D. Cumming, Daniele Caprioli, Bianca Jupp, Axel Rominger, Franklin I. Aigbirhio, Tim D. Fryer, Patrick J. Riss, Jeffrey W. Dalley · 2012 · Neuroscience & Biobehavioral Reviews
  6. Methylphenidate Attenuates Limbic Brain Inhibition after Cocaine-Cues Exposure in Cocaine Abusers
    Nora D. Volkow, Gene‐Jack Wang, Dardo G. Tomasi, Frank Telang, Joanna S. Fowler, Kith Pradhan, Millard C. Jayne, Jean Logan, Rita Z. Goldstein, Nelly Alia‐Klein et al. · 2010 · PLoS ONE
  7. Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder.
    Daniel D. Langleben, Paul D. Acton, Glenn Austin, Igor Elman, Gary Krikorian, John R. Monterosso, Orith Portnoy, Hugh W. Ridlehuber, H. William Strausś · 2002 · PubMed
  8. Genotype and ancestry modulate brain's DAT availability in healthy humans
    Shumay, Elena, Chen, John, Fowler, Joanna S., Volkow, Nora D. · 2011 · PLoS ONE
  9. Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat
    Marie L. Woolley, Kerry A. Waters, Charlie Reavill, Sharlene Bull, Laurent P. Lacroix, Abbe Martyn, Daniel M. Hutcheson, Enzo Valerio, Simon T. Bate, Declan N.C. Jones et al. · 2008 · Behavioural Pharmacology
  10. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release
    Anne S. Berry, Vyoma D. Shah, Daniella J. Furman, Robert L. White, S. Baker, J. O'Neil, M. Janabi, M. D'Esposito, W. Jagust · 2017 · Neuropsychopharmacology
  11. New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder
    Kennerly S. Patrick, Mario Ángel-González, Arthur B. Straughn, John Seth Markowitz · 2005 · Expert Opinion on Drug Delivery
  12. The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications
    James M. Swanson, Marc Lerner, Timothy L. Wigal, Kenneth W. Steinhoff, Laurence Lee Greenhill, Kelly Posner, J. Freid, S.B. Wigal · 2002 · Journal of Attention Disorders
  13. PET Imaging of Norepinephrine Transporters
    Yu‐Shin Ding, Kuo‐Shyan Lin, Jean Logan · 2006 · Current Pharmaceutical Design
  14. Systemic inflammation enhances stimulant-induced striatal dopamine elevation
    Joseph Ryan Petrulli, B Kalish, Nabeel Nabulsi, Yiyun Henry Huang, Jonas O. Hannestad, Evan D. Morris · 2017 · Translational Psychiatry
  15. Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder
    Peter Lepping, Markus Karl Huber · 2010 · CNS Drugs
  16. Latrophilins: A Neuro-Centric View of an Evolutionary Conserved Adhesion G Protein-Coupled Receptor Subfamily
    Ana L. Moreno-Salinas, Monserrat Avila-Zozaya, Paul Ugalde-Silva, David A. Hernández-Guzmán, F. Missirlis, A. Boucard · 2019 · Frontiers in Neuroscience
  17. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey
    Tohru Kodama, Takashi Kojima, Yoshiko Honda, Takayuki Hosokawa, Ken‐Ichiro Tsutsui, Masataka Watanabe · 2017 · Journal of Neuroscience
  18. Dopamine reuptake transporter (DAT) “inverse agonism” – A novel hypothesis to explain the enigmatic pharmacology of cocaine
    David J. Heal, Jane Gosden, Sharon L. Smith · 2014 · Neuropharmacology
  19. Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: Association with the dopamine transporter gene (SLC6A3)
    D. Purper-Ouakil, M. Wohl, S. Orejarena, S. Cortese, C. Boni, M. Asch, M. Mouren, P. Gorwood · 2008 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  20. Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study
    Sarah Karen Inglis, Sara Carucci, Peter Garas, Alexander Häge, Tobias Banaschewski, Jan K. Buitelaar, Regina Dittmann, Bruno Falissard, Chris P. Hollis, Hanna Kovshoff et al. · 2016 · BMJ Open
  21. Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study
    Corinde E. Wiers, Falk W. Lohoff, Jisoo Lee, Christine Muench, Clara R. Freeman, Amna Zehra, Stefano Marenco, Barbara K. Lipska, Pavan Kumar Auluck, Ningping Feng et al. · 2018 · European Journal of Neuroscience
  22. Latent-Profile Analysis Reveals Behavioral and Brain Correlates of Dopamine-Cognition Associations
    Martin Lövdén, Nina Karalija, Micael Andersson, Anders Wåhlin, Jan Axelsson, Ylva Köhncke, Lars Stiernman Jonasson, Anna Rieckmann, Goran Papenberg, Douglas D. Garrett et al. · 2017 · Cerebral Cortex
  23. Catecholaminergic modulation of the avoidance of cognitive control.
    Monja I. Froböse, Jennifer C. Swart, Jennifer Louise Cook, Dirk E. M. Geurts, Hanneke E.M. den Ouden, Roshan Cools · 2018 · Journal of Experimental Psychology General
  24. Animal models to guide clinical drug development in ADHD: lost in translation?
    Jeffery R. Wickens, Brian I. Hyland, Gail Tripp · 2011 · British Journal of Pharmacology
  25. The effect of methylphenidate on postural stability under single and dual task conditions in children with attention deficit hyperactivity disorder — A double blind randomized control trial
    Talia Jacobi‐Polishook, Zamir Shorer, Itshak Melzer · 2009 · Journal of the Neurological Sciences
  26. Catecholaminergic modulation of meta-learning
    Jennifer Louise Cook, Jennifer C. Swart, Monja I. Froböse, Andreea Oliviana Diaconescu, Dirk E. M. Geurts, Hanneke E.M. den Ouden, Roshan Cools · 2019 · eLife
  27. Sex differences in methylphenidate-induced dopamine increases in ventral striatum
    Peter Manza, Ehsan Shokri Kojori, Corinde E. Wiers, Danielle S. Kroll, Dana E. Feldman, Katherine L. McPherson, Erin Biesecker, Evan Dennis, Allison Johnson, Andrew C. Kelleher et al. · 2021 · Molecular Psychiatry
  28. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder
    Staller, Jud A, Faraone, Stephen V · 2007 · Expert Review of Neurotherapeutics
  29. Measuring Dopamine Synaptic Transmission with Molecular Imaging and Pharmacological Challenges: The State of the Art
    M. Laruelle · 2012 · Neuromethods
  30. Characterization of methylphenidate self-administration and reinstatement in the rat
    Leigh C.P. Botly, Christie L. Burton, Zoë Rizos, Paul J. Fletcher · 2008 · Psychopharmacology
  31. Predominance of D2 Receptors in Mediating Dopamine's Effects in Brain Metabolism: Effects of Alcoholism
    Nora D. Volkow, Dardo G. Tomasi, Gene‐Jack Wang, Frank Telang, Joanna S. Fowler, Jean Logan, L. Jayne Maynard, Christopher Wong · 2013 · Journal of Neuroscience
  32. Evolution of stimulants to treat ADHD: transdermal methylphenidate
    Kennerly S. Patrick, Arthur B. Straughn, Jeb S. Perkins, Mario Ángel-González · 2008 · Human Psychopharmacology Clinical and Experimental
  33. Putative therapeutic targets for symptom subtypes of adult ADHD: D4 receptor agonism and COMT inhibition improve attention and response inhibition in a novel translational animal model
    Anneka Tomlinson, Ben Grayson, Samuel Marsh, Andrew Hayward, Kay M. Marshall, Joanna Caroline Neill · 2014 · European Neuropsychopharmacology
  34. Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration
    Mihai Avram, Felix Müller, Helena Victoria Rogg, Alexandra I. Korda, Christina Andreou, Friederike Holze, Patrick Vizeli, Laura Ley, Matthias E. Liechti, Stefan Borgwardt · 2022 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  35. Rats that differentially respond to cocaine differ in their dopaminergic storage capacity of the nucleus accumbens
    Michel M. M. Verheij, Eric L.W. de Mulder, Elvira De Leonibus, Karen M. J. van Loo, Alexander Rudolf Cools · 2008 · Journal of Neurochemistry
  36. An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder
    Jan Frölich, Tobias Banaschewski, Manfred Döpfner, Anja Görtz‐Dorten · 2014 · Expert Opinion on Drug Metabolism & Toxicology
  37. Individual Differences in Dopamine Are Associated with Reward Discounting in Clinical Groups But Not in Healthy Adults
    Jaime J. Castrellon, Kendra Leigh Seaman, Jennifer L. Crawford, Jacob S. Young, Christopher T. Smith, Linh C. Dang, Ming Hsu, Ronald L. Cowan, David Harold Zald, Gregory Russell Samanez-Larkin · 2018 · Journal of Neuroscience
  38. Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD
    Jung-Chi Chang, Hsiang‐Yuan Lin, Jinglei Lv, Wen‐Yih Isaac Tseng, Susan Shur‐Fen Gau · 2021 · BMC Psychiatry
  39. Antidepressant drug development: Focus on triple monoamine reuptake inhibition
    Roger M. Lane · 2014 · Journal of Psychopharmacology
  40. Prefrontal cortex dopamine release measured in vivo with positron emission tomography: Implications for the stimulant paradigm
    Dennis Hernaus, Mitul Ashok Mehta · 2015 · NeuroImage
  41. Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice
    Ana Carolina Issy, Cristiane Salum, E.A. Del Bel · 2009 · Behavioural Brain Research
  42. Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter — Application to juvenile myoclonic epilepsy
    Ikuo Odano, Andrea Varrone, Ivanka Savić, Carolina Ciumas, Per Karlsson, Aurelija Jučaitė, Christer Halldin, Lars Farde · 2011 · NeuroImage
  43. Proceed, with caution: SPECT cerebral blood flow studies of children and adolescents with attention deficit hyperactivity disorder.
    F. Xavier Castellanos · 2002 · PubMed
  44. Attention Deficit Hyperactivity Disorder
    James M Swanson, Nora D. Volkow, Jeffrey H. Newcorn, B.J. Casey, Robert K. Moyzis, David K. Grandy, Michael I. Posner · 2005 · Encyclopedia of Cognitive Science
  45. Neuron Membrane Trafficking and Protein Kinases Involved in Autism and ADHD
    Kitagishi, Yasuko, Minami, Akari, Nakanishi, Atsuko, Ogura, Yasunori, Matsuda, Satoru · 2015 · International Journal of Molecular Sciences
  46. Catecholaminergic based therapies for functional recovery after TBI
    Nicole Danielle Osier, C. Edward Dixon · 2015 · Brain Research
  47. The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder
    Cláudia Maciel Szobot, Carla Ruffoni Ketzer, Renato D. Cunha, Maria Alice de Mattos Pimenta Parente, Daniel D. Langleben, Paul D. Acton, Flávio Pereira Kapczinski, Luís Augusto Rohde · 2003 · European Journal of Nuclear Medicine and Molecular Imaging
  48. Experimental Investigations on Dopamine Transmission Can Provide Clues on the Mechanism of the Therapeutic Effect of Amphetamine and Methylphenidate in ADHD
    Ezio Carboni, Alessandra Silvagni · 2004 · Neural Plasticity
  49. Effects of Osmotic-Release Methylphenidate on Height and Weight in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Following up to Four Years of Treatment
    Teodoro Durá-Travé, María Eugenia Yoldi-Petri, Fidel Gallinas-Victoriano, Patricia Zardoya-Santos · 2011 · Journal of Child Neurology
  50. PharmGKB summary
    Tyler Stevens, Katrin Sangkuhl, Jacob T. Brown, Russ Biagio Altman, Teri E. Klein · 2019 · Pharmacogenetics and Genomics
  51. The influence of methylphenidate on the power spectrum of ADHD children – an MEG study
    Christian Wienbruch, Isabella Paul, Susanne M. Bauer, H Kivelitz · 2005 · BMC Psychiatry
  52. Statistical Evidence Suggests that Inattention Drives Hyperactivity/Impulsivity in Attention Deficit-Hyperactivity Disorder
    Elena Sokolova, Perry Groot, Tom Claassen, Kimm J. E. van Hulzen, Jeffrey Colm Glennon, Barbara Franke, Tom Heskes, Jan K. Buitelaar · 2016 · PLoS ONE
  53. Changes in Endogenous Dopamine Induced by Methylphenidate Predict Functional Connectivity in Nonhuman Primates
    Rasmus M. Birn, Alexander K. Converse, Abigail Z. Rajala, Andrew L. Alexander, Walter F. Block, Alan B. McMillan, Bradley T. Christian, Caitlynn Filla, Dhanabalan Murali, Samuel A. Hurley et al. · 2018 · Journal of Neuroscience
  54. A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague–Dawley rats during the waking (lights off) cycle
    Mark S. Levi, Becky Divine, Joseph P. Hanig, Daniel R. Doerge, Michelle M. Vanlandingham, Nysia I. George, Nathan C. Twaddle, John F. Bowyer · 2012 · Neurotoxicology and Teratology
  55. Effects of methylphenidate on reinforcement learning depend on working memory capacity
    Mojtaba Rostami Kandroodi, Jennifer Louise Cook, Jennifer C. Swart, Monja I. Froböse, Dirk E. M. Geurts, Abdol‐Hossein Vahabie, Majid Nili Ahmadabadi, Roshan Cools, Hanneke E.M. den Ouden · 2021 · Psychopharmacology
  56. Investigating expectation and reward in human opioid addiction with [ 11 C ]raclopride PET
    Ben J. Watson, Lindsay G. Taylor, Alastair G. Reid, Sue J. Wilson, Paul R A Stokes, David James Brooks, James F. Myers, Federico Turkheimer, David Nutt, Anne R. Lingford-Hughes · 2013 · Addiction Biology
  57. Contribution of Clinical Neuroimaging to the Understanding of the Pharmacology of Methylphenidate
    Luc Zimmer · 2017 · Trends in Pharmacological Sciences
  58. Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls
    Shook, Devon, Brady, Colin, Lee, Philip S., Kenealy, Laura, Murphy, Eric R., Gaillard, William D., VanMeter, John W., Cook, Edwin H., Stein, Mark, Vaidya, Chandan J. · 2011 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  59. Searching for a Neurobiological Basis for Self-Medication Theory in ADHD Comorbid With Substance Use Disorders
    Neivo Silva, Cláudia Maciel Szobot, Ming Chi Shih, Marcelo Q. Hoexter, Carlos Eduardo Anselmi, Flávio Pechansky, Rodrigo A. Bressan, Luís Augusto Rohde · 2013 · Clinical Nuclear Medicine
  60. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: An [11C]raclopride PET study
    Alice Egerton, John P. Shotbolt, Paul R A Stokes, Ella Hirani, Rabia Ahmad, Julia Lappin, Suzanne Reeves, Mitul Ashok Mehta, Oliver David Howes, Paul M. Grasby · 2009 · NeuroImage
  61. Successful methylphenidate treatment of early onset extreme obesity in a child with a melanocortin-4 receptor gene mutation and attention deficit/hyperactivity disorder
    Özgür Albayrak, Beate Albrecht, Susann Scherag, Nikolaus Barth, Anke Hinney, Johannes Hebebrand · 2011 · European Journal of Pharmacology
  62. Attention-Deficit/Hyperactivity Disorder: Advancing on Pharmacogenomics
    Guilherme V. Polanczyk, Cristian Zeni, Júlia Pasqualini Genro, Tatiana Roman, Mara Helena Hutz, Luís Augusto Rohde · 2005 · Pharmacogenomics
  63. Does Chirality Matter?
    Declan Quinn · 2008 · Journal of Clinical Psychopharmacology
  64. Methylphenidate: Mechanism of Action and Clinical Update
    Lawrence David Scahill, Deirdre H. Carroll, Kathleen Burke · 2004 · Journal of Child and Adolescent Psychiatric Nursing
  65. Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study
    Zheng, Huirong, Jia, Fujun, Han, Hongying, Wang, Shibin, Guo, Guangquan, Quan, Dongming, Li, Gang, Huang, Huiyan · 2019 · European Neuropsychopharmacology
  66. Methylphenidate-Induced Orofacial and Extremity Dyskinesia
    Judit Balázs, Márta Besnyő, Júlia Gádoros · 2007 · Journal of Child and Adolescent Psychopharmacology
  67. Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: Potential role for 5-HT1B receptor
    Vincent Van Waes, S. Ehrlich, Joel A. Beverley, H. Steiner · 2014 · Neuropharmacology
  68. Medication and creativity in Attention Deficit Hyperactivity Disorder (ADHD)
    Gracia González-Carpio Hernández, Juan Serrano Selva · 2016 · Psicothema
  69. Impaired transcallosally mediated motor inhibition in adults with attention-deficit/hyperactivity disorder is modulated by methylphenidate
    Jacqueline Hoeppner, Roland Wandschneider, Martin Neumeyer, Wolfgang Gierow, Frank Haessler, Sabine Christiane Herpertz, Johannes A Buchmann · 2008 · Journal of Neural Transmission
  70. Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats
    Yoshinori Masuo, Masami Ishido, Masatoshi Morita, Syuichi Oka · 2002 · Neuroscience Letters
  71. Methylphenidate increases willingness to perform effort in adults with ADHD
    Merideth A. Addicott, Julia C. Schechter, Jeffrey J. Sapyta, James P. Selig, Scott Haden Kollins, Margaret Danielle Weiss · 2019 · Pharmacology Biochemistry and Behavior
  72. Differential contribution of storage pools to the extracellular amount of accumbal dopamine in high and low responders to novelty: effects of reserpine1
    Michel M. M. Verheij, A.R. Cools · 2006 · Journal of Neurochemistry
  73. Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior
    H. Steiner, Brandon L. Warren, Vincent Van Waes, Carlos A. Bolaños-Guzmán · 2014 · Progress in Brain Research
  74. Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
    Yoko Nakanishi, Toyosaku Ota, Junzo Iida, Kazuhiko Yamamuro, Naoko Kishimoto, Kosuke Okazaki, Taishiro Kishimoto · 2017 · Child and Adolescent Psychiatry and Mental Health
  75. Differential long-term medication impact on executive function and delay aversion in ADHD
    Belén Rubio Morell, Sergio Hernández Expósito · 2017 · Applied Neuropsychology Child
  76. Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder
    Gene‐Jack Wang, Corinde E. Wiers, Elena Shumay, Dardo G. Tomasi, Kai Yuan, Christopher Wong, Jean Logan, Joanna S. Fowler, Nora D. Volkow · 2019 · Translational Psychiatry
  77. Brain processes in discounting: consequences of adolescent methylphenidate exposure.
    W. Adriani, Francesca Zoratto, G. Laviola · 2012 · Current topics in behavioral neurosciences
  78. Initial Comparison of ntPET with Microdialysis Measurements of Methamphetamine-Induced Dopamine Release in Rats: Support for Estimation of Dopamine Curves from PET Data
    E. Morris, M. Normandin, W. Schiffer · 2008 · Molecular Imaging and Biology
  79. A Positron Emission Tomography Study Examining The Dopaminergic Activity of Armodafinil in Adults Using [11C]Altropane and [11C]Raclopride
    Thomas J. Spencer, Bertha Kalifon Madras, Ali A. Bonab, Darin Dean Dougherty, Allison Clarke, Tara Mirto, Jessica Martin, Alan J. Fischman · 2010 · Biological Psychiatry
  80. Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli
    Thorsten Kienast, Thomas Siessmeier, Jana Wrase, Dieter F. Braus, Michael N. Smolka, Hans Georg Buchholz, Michael A. Rapp, Mathias Schreckenberger, Frank Rösch, Paul D. Cumming et al. · 2008 · European Journal of Nuclear Medicine and Molecular Imaging
  81. Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat
    Yoshinori Masuo, Masami Ishido, Masatoshi Morita, Hirofumi Sawa, Kazuo Nagashima, Etsuo Niki · 2007 · European Journal of Neuroscience
  82. Methylphenidate Modifies Overflow and Presynaptic Compartmentalization of Dopamine via an α-Synuclein-Dependent Mechanism
    Heramb Chadchankar, Jouni A. Ihalainen, Heikki Tanila, Leonid Yavich · 2012 · Journal of Pharmacology and Experimental Therapeutics
  83. Intrinsic Brain Connectivity Following Long-Term Treatment with Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder
    Lucas Battel, Renata Rocha Kieling, Christian Kieling, Maurício Anés, Nathassia Kadletz Aurich, Jaderson Costa da Costa, Luís Augusto Rohde, Alexandre R. Franco · 2016 · Journal of Child and Adolescent Psychopharmacology
  84. Behavioral and neurochemical characterization of the mlh mutant mice lacking otoconia
    Marianna Manes, Mariana de Souza Aranha Garcia Gomes, Thaísa Meira Sandini, Julia Zaccarelli‐Magalhães, Jorge Camilo Flório, Sandra Regina Alexandre-Ribeiro, Danilo Wadt, Maria Martha Bernardi, Sílvia Maria Gomes Massironi, Cláudia Madalena Cabrera Mori · 2018 · Behavioural Brain Research
  85. Neurodevelopmental and neurodegenerative diseases – Is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples
    Dorothée E. Lulé, Albert Christian Ludolph, Andrea G. Ludolph · 2008 · Medical Hypotheses
  86. Fluoxetine Potentiates Oral Methylphenidate-Induced Gene Regulation in the Rat Striatum
    Connor Moon, Matt Marion, Panayotis K. Thanos, Heinz Steiner · 2021 · Molecular Neurobiology
  87. Long-term methylphenidate treatment down-regulates c-fos in the striatum of male CD-1 mice
    Christianne M. Hawken, Richard E. Brown, NORMAND J. CARREY, Michael Wilkinson · 2004 · Neuroreport
  88. Effects of methylphenidate on resting-state brain activity in normal adults: an fMRI study
    Yihong Zhu, Bin Gao, Jianming Hua, Weibo Liu, Yichao Deng, Lijie Zhang, Biao Jiang, Yu‐Feng Zang · 2013 · Neuroscience Bulletin
  89. The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro
    Jasmin Bartl, Ferruccio Palazzesi, Michele Parrinello, Leif G. Hommers, Peter Riederer, Susanne Walitza, Edna Grünblatt · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  90. Effect of Single Dose Methylphenidate on Walking and Postural Stability Under Single- and Dual-Task Conditions in Older Adults--A Double-Blind Randomized Control Trial
    Zamir Shorer, Yaacov G. Bachner, T. Guy, Itshak Melzer · 2013 · The Journals of Gerontology Series A
  91. Motor activity and gene expression in rats with neonatal 6‐hydroxydopamine lesions
    Yoshinori Masuo, Masami Ishido, Masatoshi Morita, Syuichi Oka, Etsuo Niki · 2004 · Journal of Neurochemistry
  92. Pharmacological challenge and synaptic response – assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET)
    Susanne Nikolaus, Rolf Larisch, Henning Vosberg, Markus Beu, Andreas Wirrwar, Christina Antke, Konstantin Kley, Maria A. de Souza Silva, Joseph P. Huston, Hans‐Wilhelm Müller · 2011 · Reviews in the Neurosciences
  93. Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder
    James J. McGough, Caroly S. Pataki, Robert Suddath · 2005 · Expert Review of Neurotherapeutics
  94. Algorithmically designed peptides ameliorate behavioral defects in animal model of ADHD by an allosteric mechanism
    Becky L. Kinkead, Karen A. Selz, Michael J. Owens, Arnold J. Mandell · 2006 · Journal of Neuroscience Methods
  95. The role of the D3 dopamine receptor and its partial agonist cariprazine in patients with schizophrenia and substance use disorder
    H. Grunze · 2023 · Expert Opinion on Pharmacotherapy
  96. Dopamine transporter density and behavioral response to methylphenidate in a hyperlocomotor rat model
    Katsumasa T. Muneoka, Makiko Kuwagata, Masaaki Iwata, Yukihiko Shirayama, Tetsuo Ogawa, Morikuni Takigawa · 2006 · Congenital Anomalies
  97. Long-Term Effects of Chronic Oral Ritalin Administration on Cognitive and Neural Development in Adolescent Wistar Kyoto Rats
    Margery C. Pardey, Natasha N. Kumar, Ann K. Goodchild, Kelly J. Clemens, Judi Homewood, Jennifer Louise Cornish · 2012 · Brain Sciences
  98. No association between catechol-O-methyltransferase (COMT) genotype and attention deficit hyperactivity disorder (ADHD) in Japanese children
    Chiho Yatsuga, Daiki Toyohisa, Takashi X. Fujisawa, Shota Nishitani, Kazuyuki Shinohara, Naomi Matsuura, Shinobu Ikeda, Masaaki Muramatsu, Akinobu Hamada, Akemi Tomoda · 2013 · Brain and Development
  99. Examining the role of dopamine in methylphenidate’s effects on resting brain function
    Dardo G. Tomasi, Peter Manza, Weizheng Yan, Ehsan Shokri Kojori, Şükrü Barış Demiral, Michele-Vera Yonga, Katherine L. McPherson, Catherine L. Biesecker, Evan Dennis, Allison Johnson et al. · 2023 · Proceedings of the National Academy of Sciences
  100. Psychostimulants in Attention Deficit Hyperactivity Disorder
    Daniel F. Connor · 2005 · Contemporary clinical neuroscience